Sandra Domene Ochoa
Overview
Explore the profile of Sandra Domene Ochoa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montero M, Domene Ochoa S, Lopez-Causape C, Luque S, Sorli L, Campillo N, et al.
Microbiol Spectr
. 2021 Jul;
9(1):e0058521.
PMID: 34319141
Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics against Pseudomonas aeruginosa infections. Data from assays of CZA combinations, however, are scarce. The objective of...
2.
Montero M, Domene Ochoa S, Lopez-Causape C, VanScoy B, Luque S, Sorli L, et al.
Antimicrob Agents Chemother
. 2020 Feb;
64(4).
PMID: 32041712
Combination therapy is an attractive therapeutic option for extensively drug-resistant (XDR) infections. Colistin has been the only treatment available for these infections for many years, but its results are suboptimal....
3.
Montero M, Domene Ochoa S, Lopez-Causape C, VanScoy B, Luque S, Sorli L, et al.
J Glob Antimicrob Resist
. 2019 Jun;
18:37-44.
PMID: 31154007
Background: Extensively drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) and particularly P. aeruginosa high-risk clones, are of growing concern because treatment options are limited. For years, colistin monotherapy has been the...